Search

Your search keyword '"Van Crevel, R"' showing total 577 results

Search Constraints

Start Over You searched for: Author "Van Crevel, R" Remove constraint Author: "Van Crevel, R"
577 results on '"Van Crevel, R"'

Search Results

2. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

5. De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study

8. Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study

9. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

10. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

11. Pediatric tuberculous meningitis: Model‐based approach to determining optimal doses of the anti‐tuberculosis drugs rifampin and levofloxacin for children

15. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

19. MUC5AC genetic variation is associated with tuberculous meningitis CSF cytokine responses and mortality

22. Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes

23. SARS‑CoV‑2 RNA in exhaled air of hospitalized COVID‑19 patients

25. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

26. Management of drug interactions with direct‐acting antivirals in Dutch HIV/hepatitis C virus‐coinfected patients: adequate but not perfect

27. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

30. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

31. An integrative genomics approach identifies KDM4 as a modulator of trained immunity.

32. Successful testing and treating of HIV/AIDS in Indonesia depends on the addiction treatment modality

33. A highly virulent variant of HIV-1 circulating in the Netherlands

36. Reaching HCV micro-elimination in HIV/HCV co-infected individuals in the Netherlands: exploring remaining barriers to HCV treatment

37. An optimized protocol for dual RNA-Seq of human macrophages infected with Mycobacterium avium

38. The effect of a structured clinical algorithm on glycemic control in patients with combined tuberculosis and diabetes in Indonesia: a randomized trial

39. Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in Tuberculosis

40. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19

41. Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes

44. Diabetes Mellitus Among Pulmonary Tuberculosis Patients From 4 Tuberculosis-endemic Countries: The TANDEM Study

45. High tuberculosis incidence among people living with diabetes in Indonesia

46. Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly

47. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection

48. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis

49. Rewiring of glucose metabolism defines trained immunity induced by oxidized low-density lipoprotein

50. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection

Catalog

Books, media, physical & digital resources